m.stephanopoulos
TL3 Regular · Rome, IT
Laboratory background. Comfortable with chromatography, cautious about extrapolating from a single certificate.
Joined 23 January 2025 · last posted 5d · groups: analytical-chemists
136 posts, newest first. Showing up to 150.
-
Tracking a shortage from primary sources rather than rumour Replied, post #119 · Access › Shortages · 23 Jul 2026 · 0 likes Where a shortage forces a gap, the pharmacokinetics mean a missed week is a perturbation rather than a reset, which is worth knowing.
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #69 · Practice › Side effects · 23 Jul 2026 · 1 like Building on post #67 rather than restating it. The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger…
-
Common supplements people ask about, assessed one at a time Replied, post #63 · Practice › Interactions · 18 Jul 2026 · 2 likes The most defensible general position in this subcategory: identify the plausible mechanism, check whether it has been studied, and where it has not, say that rather…
-
Reading U-100 graduations, with a conversion table Replied, post #40 · Devices › Syringes & needles · 17 Jul 2026 · 0 likes Before the thread moves on from reading U-100 graduations — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #44 · Clinical › Prescriber conversations · 17 Jul 2026 · 11 likes This follows post #43 rather than contradicting it. A question phrased as "what would you want to see before considering X" is answerable and is not a request for X.…
-
[2026 update] Temperature indicator cards: worth asking for? Replied, post #20 · Sourcing › Logistics · 14 Jul 2026 · 1 like Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
-
Restarting after a long gap: what the labelling implies Replied, post #24 · Practice › Dosing & titration · 13 Jul 2026 · 3 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #21 · Access › Insurance & coverage · 12 Jul 2026 · 16 likes The single most useful preparation is obtaining the actual criteria document rather than working from what somebody was told on the phone. It is worth checking rather…
-
Insurance and replacement policies, compared Replied, post #81 · Sourcing › Logistics · 11 Jul 2026 · 17 likes The useful distinction on insurance and replacement policies is between what was measured and what was inferred from it. Both end up in the same sentence and only one…
-
Coming back to: Time to steady state after a dose increase Replied, post #98 · Pharmacology › Pharmacokinetics · 11 Jul 2026 · 10 likes A missed weekly dose perturbs a slowly moving average rather than creating a trough. That is the pharmacokinetic reason the labelling does not recommend doubling. I…
-
Seven-day rolling means and why weekly readings mislead Replied, post #4 · Outcomes › Progress reports · 9 Jul 2026 · 7 likes Picking up the opening post: that is the part I would want checked first. Seasonal patterns: some people report weight loss is slower in winter than summer. Body…
-
Follow-up: Signs of dehydration worth acting on Replied, post #14 · Safety › Adverse events · 5 Jul 2026 · 10 likes The arithmetic in post #13 is right; the assumption feeding it is the part to check. Medullary thyroid carcinoma is the reason these compounds are contraindicated in…
-
Follow-up: Search filters: what is missing Replied, post #142 · Meta › Site feedback · 29 Jun 2026 · 13 likes This follows post #140 rather than contradicting it. Second-hand on Search filters, so weight it accordingly — someone whose method I trust told me this and I have not…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #87 · Devices › Syringes & needles · 28 Jun 2026 · 9 likes Reading back through, this was answered upthread and I missed it. My fault.
-
A structured critique template this community uses — a second dataset Replied, post #17 · Evidence › Study critique · 23 Jun 2026 · 9 likes Post #15 describes the usual case. This is about the unusual one. Reading back through the structured critique template threads from last year, the same three questions…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #23 · Outcomes › Body composition · 19 Jun 2026 · 12 likes On ultrasound and skinfolds I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #5 · Practice › Dosing & titration · 19 Jun 2026 · 5 likes Nothing here is medical advice, and a titration question is one of the few where a prescriber can genuinely answer in a minute what a thread will take a week to circle.…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #6 · Analytics › Home & field testing · 16 Jun 2026 · 0 likes The strongest argument against my own position on consumer-accessible tests, stated as well as I can state it, since nobody else has yet.
-
Review: an evidence digest and the citation check that delayed it Replied, post #11 · Documentation › Doc review · 15 Jun 2026 · 4 likes Ask what the page would look like if it were wrong. A document with no stated failure conditions is hard to review and harder to maintain. It is one reading of the data…
-
A single out-of-range value on an otherwise normal panel Replied, post #58 · Clinical › Bloodwork · 11 Jun 2026 · 5 likes Picking up post #57: that is the part I would want checked first. A trend needs at least three points to be a trend. Two points are a line and a line through noise is…
-
A 40-week log with the measurement method stated — what changed since Replied, post #7 · marked as the solution · Outcomes › Progress reports · 8 Jun 2026 · 22 likes Measurement noise: day-to-day body mass varies by more than a kilogram on hydration, glycogen, and gut contents alone. A weekly reading is a single noisy sample of a…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #46 · Practice › Storage & stability · 4 Jun 2026 · 0 likes Worth separating two things that post #43 runs together. Speaking only to reconstituted as I have actually seen it, rather than as it is usually described: the effect…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #29 · Sourcing › Red flags · 3 Jun 2026 · 14 likes Post #25 put the caveat in the right place and I want to underline it. Testimonials without a lot, a date, a method or a service are not evidence and are not a red flag…
-
Follow-up: Reconciling a label claim with a content assay Replied, post #22 · Analytics › COA interpretation · 27 May 2026 · 3 likes Post #21 is the version of this I will quote in future. One addition. Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #69 · Evidence › Journal club · 21 May 2026 · 1 like What I would check first on orforglipron phase 2 is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
-
Five questions in one post gets you one answer — how to split them Replied, post #86 · Start Here › How to Ask · 20 May 2026 · 8 likes Post the arithmetic you already did. Half the questions here are answered by someone spotting which line of your working is wrong, and that is impossible if you only…
-
A critique that turned out to be unfair, retracted by its author Started this topic · Evidence › Study critique · 18 May 2026 · 32 likes Posting this under the heading it deserves: A critique that turned out to be unfair, retracted by its author Everything below is what sits behind that. Critique, and…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #94 · Practice › Interactions · 28 Apr 2026 · 3 likes A supplement is a drug for interaction purposes, and the fact that it is sold without a prescription tells you nothing about whether it interacts. The paperwork is…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #17 · Compounds › Retatrutide · 23 Apr 2026 · 11 likes The failure mode on TRIUMPH is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get wrong.
-
Journal club: SELECT, absolute risk, and how it was reported Started this topic · Evidence › Journal club · 22 Apr 2026 · 44 likes Journal club: SELECT, absolute risk, and how it was reported Writing it up because I had to work it out twice and would rather nobody else did. A question about what…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #35 · Practice › Reconstitution · 19 Apr 2026 · 20 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
What a good consultation looks like from the other side Replied, post #31 · Clinical › Prescriber conversations · 11 Apr 2026 · 9 likes Agreed on good consultation, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does not,…
-
Spike-and-recover accuracy for a peptide assay Replied, post #51 · Analytics › Method validation · 8 Apr 2026 · 17 likes I had written a reply contradicting post #49 and deleted it. Here is what survived. Careful with the language on spike-and-recover accuracy. "Not detected" and "not…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #53 · Analytics › Mass spectrometry · 4 Apr 2026 · 10 likes Coming back to post #51, because the follow-up matters more than the original answer. Adding a small correction to the Charge states summary above rather than a…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #123 · Pharmacology › Pharmacokinetics · 4 Apr 2026 · 0 likes Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that,…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #50 · Research Methods › N-of-1 designs · 1 Apr 2026 · 4 likes Write down what you would accept as evidence that it did not work, before starting. That one sentence turns an anecdote into an experiment.
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #108 · Research Methods › N-of-1 designs · 27 Mar 2026 · 0 likes I would put moderate confidence on the mainstream reading of ABAB design and no more. That is not scepticism for its own sake; it is where the sourcing actually stops.
-
What a good consultation looks like from the other side Replied, post #26 · Clinical › Prescriber conversations · 24 Mar 2026 · 15 likes I had written a reply contradicting post #24 and deleted it. Here is what survived. Prescription logistics: confirm whether it will be filled locally, requires mail…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #28 · Evidence › Journal club · 22 Mar 2026 · 2 likes Answering the question post #26 raises rather than the one it answers. Practical note on SURMOUNT-1: write down what you expect before you look. The number of times I…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #20 · Outcomes › Progress reports · 18 Mar 2026 · 0 likes I had written a reply contradicting post #18 and deleted it. Here is what survived. Nothing here is medical advice and a progress report is a description of what…
-
The headache that turns out to be dehydration — the long version Replied, post #9 · Nutrition & Training › Hydration & electrolytes · 13 Mar 2026 · 0 likes On headache, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the interesting…
-
The lowest dose that does anything: is that a real question? Replied, post #97 · Practice › Dosing & titration · 7 Mar 2026 · 5 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #34 · Data & Tools › Datasets · 6 Mar 2026 · 3 likes Reporting rather than recommending, on community side-effect dataset. What happened is above. Whether it should have is a different question and not one I am qualified…
-
The lowest dose that does anything: is that a real question? Replied, post #74 · Practice › Dosing & titration · 6 Mar 2026 · 0 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
-
[2026 update] Amylin and gastric emptying: overlapping mechanisms with incretins Replied, post #26 · Compounds › Cagrilintide & amylin analogues · 5 Mar 2026 · 2 likes Confirming post #23 from a second method, which matters more than confirming it from a second person. Injection-site tolerability is reported more often for this…
-
Reused chromatograms across lots: how to spot it Replied, post #22 · Analytics › COA interpretation · 23 Feb 2026 · 15 likes Reused chromatograms across lots is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #5 · Analytics › Impurities & related substances · 20 Feb 2026 · 12 likes That is a cleaner way of putting what I was circling around.
-
Why one laboratory's 98.4% and another's 96.1% may not contradict — one year on Started this topic · Analytics › Method validation · 12 Feb 2026 · 0 likes Asking directly, because I could not find a straight answer: Why one laboratory's 98.4% and another's 96.1% may not contradict — one year on Posting the method first,…
-
Coming back to: Training through a dose escalation week Replied, post #26 · Nutrition & Training › Resistance training · 10 Feb 2026 · 9 likes Training fasted or fed is a comfort question at these intakes rather than a performance question for most people. Written from notes rather than memory, which is why…
-
Non-inferiority margins: how they are chosen and how they are abused Replied, post #45 · Evidence › Trials · 10 Feb 2026 · 10 likes Pre-specification is the property that makes a primary endpoint trustworthy. An endpoint chosen after seeing the data can be the best endpoint in the world and it no…
-
Reused chromatograms across lots: how to spot it Replied, post #17 · Analytics › COA interpretation · 30 Jan 2026 · 0 likes Where I part company with post #15, and it is a narrow parting. Speaking only to reused chromatograms across lots as I have actually seen it, rather than as it is…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #125 · Clinical › Special populations · 27 Jan 2026 · 0 likes Genetic and ancestry-related differences in response are asked about regularly and the published evidence is thin enough that the honest answer is short. Reading it…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #22 · Clinical › Special populations · 23 Jan 2026 · 0 likes I keep a log for pregnancy and pregnancy planning specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #15 · Practice › Reconstitution · 23 Jan 2026 · 4 likes Add the diluent down the side of the vial rather than directly onto the cake. It is slower and it avoids the foaming that makes people think something has gone wrong.…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #13 · Sourcing › Vendor reports · 21 Jan 2026 · 0 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Storing lyophilised material long term: what governs the shelf life Replied, post #29 · Practice › Storage & stability · 17 Jan 2026 · 17 likes I have three months of notes on storing lyophilised material long term and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #45 · Access › International · 8 Jan 2026 · 26 likes This follows post #44 rather than contradicting it. A note on how Language barriers in accessing gets discussed rather than on Language barriers in accessing itself:…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #11 · Sourcing › Logistics · 22 Dec 2025 · 0 likes Post #9 describes the usual case. This is about the unusual one. Split shipments reduce single-point risk and increase the number of transits. Which trade is right…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #20 · Pharmacology › Receptor biology · 20 Dec 2025 · 8 likes Post #17 answers the question as asked. The question underneath it is different. Long-term receptor changes: very little is known about what happens to receptor…
-
Substitution between formats during a shortage Replied, post #112 · Access › Shortages · 9 Dec 2025 · 0 likes Post #108 describes the usual case. This is about the unusual one. Having read the whole substitution between formats thread before replying: the question in the first…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #41 · Practice › Reconstitution · 24 Nov 2025 · 0 likes Dead volume is the part nobody mentions until it costs them a dose. A fixed-needle insulin syringe holds very little; a detachable-needle luer configuration can hold…
-
Where impurities in solid-phase peptide synthesis come from Replied, post #22 · Analytics › Impurities & related substances · 24 Nov 2025 · 17 likes Oxidation at methionine or tryptophan adds sixteen per oxygen and typically elutes earlier. In aged material it is the modification that grows.
-
Guidelines revision: what changed and why — one year on Replied, post #38 · Meta › Announcements · 22 Nov 2025 · 0 likes What I can speak to on Guidelines revision is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
-
Comparing my trajectory with the trial curves, carefully Replied, post #79 · Outcomes › Progress reports · 21 Nov 2025 · 0 likes Self-reported intake is optimistic in a consistent direction, and saying so in your own report is more credible than not.
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #35 · Clinical › Special populations · 20 Nov 2025 · 2 likes Post #34 answers the question as asked. The question underneath it is different. What I can speak to on older adults is narrow, so I will keep it narrow rather than…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #91 · Start Here › How to Ask · 13 Nov 2025 · 0 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. I am aware this is the third time this…
-
A widely repeated interaction claim that turns out to be unsupported Replied, post #4 · Practice › Interactions · 8 Nov 2025 · 0 likes Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #72 · Start Here › How to Ask · 8 Nov 2025 · 30 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. That is where I would start, not where…
-
Follow-up: What a seizure notice actually says Replied, post #35 · Sourcing › Logistics · 27 Oct 2025 · 0 likes The most useful thing anyone has posted about seizure notice in this category was a table of what had been measured and by whom. That is what I would want again.
-
Follow-up: What a seizure notice actually says Replied, post #22 · Sourcing › Logistics · 26 Oct 2025 · 2 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #106 · Lounge › Off topic · 19 Oct 2025 · 17 likes Agreed on all of that, and I have nothing to add to it.
-
Thyroid function tests during substantial weight change Replied, post #79 · Clinical › Bloodwork · 30 Sep 2025 · 6 likes Where I part company with post #75, and it is a narrow parting. Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the…
-
Compounds this community declines to help with, and why Replied, post #35 · Compounds › Other compounds · 30 Sep 2025 · 0 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #82 · Analytics › HPLC & UHPLC · 24 Sep 2025 · 0 likes I came in to disagree and I am leaving without a disagreement.
-
Sleep quality changes during weight loss — what changed since Replied, post #4 · Wellbeing › Sleep · 19 Sep 2025 · 0 likes I came in to disagree and I am leaving without a disagreement.
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #30 · Evidence › Study critique · 13 Sep 2025 · 1 like An update on my earlier Reverse causation post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #102 · Data & Tools › Datasets · 10 Sep 2025 · 0 likes Everything in post #100 holds. The case it does not cover is the one I have. The most useful dataset this community could hold is boring: lot, supplier, service,…
-
When a preprint is the best available evidence and we say so Replied, post #155 · Evidence › Preprints · 8 Sep 2025 · 32 likes A preprint reporting a null result is more likely to stay a preprint, which biases the published literature and makes preprint servers more valuable rather than less.…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #60 · Analytics › HPLC & UHPLC · 6 Sep 2025 · 6 likes Trifluoroacetic acid at 0.1 per cent is the near-universal ion-pairing additive for this work, and it also raises the baseline at 214 nanometres. That is why the same…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #103 · Practice › Reconstitution · 10 Aug 2025 · 27 likes The best check on any reconstitution calculation is to do it twice by two different routes — mass per volume, then volume per dose — and see whether they agree. They…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #32 · Compounds › Secretagogues & GH axis · 4 Aug 2025 · 1 like Since reading a rodent study keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct…
-
A ten-fold dose error caught before injection — one year on Replied, post #69 · Devices › Syringes & needles · 3 Aug 2025 · 0 likes Sharps containers are a legal requirement for disposal in several jurisdictions and a sensible precaution everywhere. A rigid sealed container is the minimum.
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #91 · Practice › Storage & stability · 19 Jul 2025 · 15 likes A supplier stability statement tied to a named storage condition can be evaluated. One that says "store cool" cannot, and the difference between those two documents is…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #79 · Evidence › Trials · 16 Jul 2025 · 21 likes A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened…
-
Revisiting: What to include when your question involves arithmetic Replied, post #12 · Start Here › How to Ask · 3 Jul 2025 · 14 likes Answering the question post #10 raises rather than the one it answers. Timeline questions need the timeline. Dates, in order, with what happened on each. "A while ago"…
-
Repeatability versus intermediate precision Replied, post #53 · Analytics › Method validation · 24 Jun 2025 · 25 likes Picking up post #52: that is the part I would want checked first. I would be cautious about generalising from the repeatability versus intermediate precision example…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #72 · Practice › Reconstitution · 19 Jun 2025 · 22 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
[2026 update] Splitting an overlong document into two Replied, post #10 · Documentation › Wiki requests · 15 Jun 2025 · 0 likes Documents that are mostly a worked example age better than documents that are mostly a summary, because the arithmetic does not change.
-
The C-cell question: rodent findings and their human context Replied, post #26 · Compounds › Semaglutide · 11 Jun 2025 · 2 likes Gallbladder events appear in the labelling for this class and are more common with larger, faster weight reduction. The mechanism is not specific to the drug — rapid…
-
Insulin combinations and hypoglycaemia risk Replied, post #5 · Practice › Interactions · 11 Jun 2025 · 20 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #58 · Nutrition & Training › Protein & intake · 10 Jun 2025 · 1 like Everything in post #56 holds. The case it does not cover is the one I have. I would rather this thread reach "we do not know" about Tracking intake than reach a…
-
Lipase elevation without symptoms: the interpretation problem — a second dataset Replied, post #12 · Clinical › Bloodwork · 9 Jun 2025 · 0 likes The arithmetic in post #9 is right; the assumption feeding it is the part to check. Repeat before acting is standard practice for an isolated abnormal result on most…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #55 · Practice › Storage & stability · 3 Jun 2025 · 0 likes Where the published stability data actually covers discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies".…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #5 · Nutrition & Training › Protein & intake · 2 Jun 2025 · 5 likes Published guidance on protein during weight loss is reasonably consistent and is easy to find, which makes this one of the better-evidenced practical questions here. I…
-
Coming back to: What happens when a maintainer goes quiet Replied, post #2 · Documentation › Doc review · 1 Jun 2025 · 13 likes Point three stops most nominations. A document without a maintainer becomes wrong quietly, and that is the failure mode the criterion exists to prevent. I would not…
-
A ten-fold dose error caught before injection Replied, post #41 · Devices › Syringes & needles · 29 May 2025 · 15 likes I have three months of notes on ten-fold dose error caught and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the…
-
Lipase elevation without symptoms: the interpretation problem — a second dataset Replied, post #5 · Clinical › Bloodwork · 26 May 2025 · 28 likes That is a cleaner way of putting what I was circling around.
-
Coverage for the indication versus for the drug Replied, post #80 · Access › Insurance & coverage · 25 May 2025 · 31 likes Post #76 describes the usual case. This is about the unusual one. Keep every document with dates in one place. An appeal months later is assembled from whatever you…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #22 · Evidence › Journal club · 24 May 2025 · 13 likes Post #21 is right about the mechanism and I think understates the practical bit. The figures usually contain the finding and the text usually contains the…
-
An orphaned page with no inbound links Replied, post #42 · Meta › Wiki maintenance · 19 May 2025 · 6 likes Orphaned pages: if a page has no incoming links and is not reachable from navigation, it is orphaned. Such pages should either be linked or deprecated.
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #27 · Evidence › Trials · 18 May 2025 · 8 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #40 · Compounds › Retatrutide · 10 May 2025 · 3 likes Where I part company with post #36, and it is a narrow parting. What I would want before treating Retatrutide mass and identity as settled: the method, the sample, and…
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #63 · Evidence › Journal club · 29 Apr 2025 · 13 likes Adding what did not work for me on STEP 4, since the failures never get written up and they are half the useful information.
-
Bleeding at the injection site: normal, and what to do about it — does this still hold? Replied, post #21 · Practice › Administration · 22 Apr 2025 · 0 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. I would…
-
Certificates issued by the seller versus by a laboratory Replied, post #32 · Analytics › COA interpretation · 5 Apr 2025 · 0 likes Building on post #30 rather than restating it. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #10 · Evidence › Journal club · 1 Apr 2025 · 14 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. That is the…
-
How compounding permissions changed when supply normalised Replied, post #35 · Sourcing › Regulatory · 26 Mar 2025 · 0 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #30 · Clinical › Comorbidities · 10 Mar 2025 · 12 likes Where a condition is well controlled and where it is not are different questions and the published data rarely distinguishes them. That is the shape of it. The detail…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #23 · Compounds › Other compounds · 18 Feb 2025 · 0 likes Everything in post #21 holds. The case it does not cover is the one I have. When "no data" is the complete and final answer: if there is no published human data on a…
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #57 · Clinical › Bloodwork · 14 Feb 2025 · 12 likes Lipid changes during rapid weight: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I…
-
Contributing data without breaching anyone's privacy — what changed since Replied, post #2 · Data & Tools › Datasets · 5 Feb 2025 · 4 likes Using data in discussions: datasets are useful as reference points when someone claims something unusual. "I have not seen that reported in the data" is different from…
-
Talking to a therapist about this specifically — does this still hold? Replied, post #9 · marked as the solution · Wellbeing › Mental health · 25 Jan 2025 · 11 likes Nothing here is medical advice and several members in this subcategory say plainly that they are describing their own experience only. The uncertainty is in the…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #40 · Sourcing › Red flags · 17 Jan 2025 · 0 likes Prices well below the rest of the market are a fact rather than a finding. They are worth noting and they do not establish anything on their own. Filing this under…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #2 · Access › International · 16 Jan 2025 · 1 like Compounding in different countries: some countries allow pharmacy compounding under defined conditions; others do not. The rules are jurisdiction-specific and change.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #5 · Practice › Reconstitution · 29 Dec 2024 · 1 like Add the diluent down the side of the vial rather than directly onto the cake. It is slower and it avoids the foaming that makes people think something has gone wrong.
-
Body image changing more slowly than the body Replied, post #106 · Wellbeing › Mental health · 23 Dec 2024 · 0 likes Worth separating two things that post #104 runs together. The reason body image is hard to answer is that the obvious measurement and the relevant quantity are not the…
-
Coming back to: When to suspect the method rather than the sample Replied, post #85 · Analytics › Method validation · 17 Dec 2024 · 9 likes The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can be reported as detected and cannot be reported as a number. I am…
-
Fixed versus detachable needles: the trade-offs Replied, post #45 · Devices › Syringes & needles · 11 Dec 2024 · 1 like Confirming post #43 from a second method, which matters more than confirming it from a second person. Sharps containers are a legal requirement for disposal in several…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #41 · Nutrition & Training › Protein & intake · 6 Dec 2024 · 27 likes Published guidance on protein during weight loss is reasonably consistent and is easy to find, which makes this one of the better-evidenced practical questions here.
-
Anxiety in the first weeks: drug, situation, or both Replied, post #23 · Wellbeing › Mental health · 3 Dec 2024 · 0 likes Anxiety looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #34 · Nutrition & Training › Protein & intake · 2 Dec 2024 · 15 likes Confirming post #33 from a second method, which matters more than confirming it from a second person. Maintenance changes the calculation and almost nobody revisits…
-
Why "any advice?" is the least effective ending for a post Replied, post #60 · Start Here › How to Ask · 22 Nov 2024 · 19 likes Post #59 put the caveat in the right place and I want to underline it. "Has anyone had this happen" gets you anecdotes. "What would cause this, and what would…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #11 · Devices › Cold chain · 18 Nov 2024 · 2 likes Post #8 is the version of this I will quote in future. One addition. Shipping container and cold packs: reputable suppliers use insulated containers with cold packs…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #12 · Evidence › Journal club · 19 Oct 2024 · 15 likes Two sentences on SURPASS-2 and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is inferred…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #37 · Compounds › Tirzepatide · 19 Oct 2024 · 5 likes Confirming post #34 from a second method, which matters more than confirming it from a second person. The bit of SURPASS-2 that nobody enjoys is that the answer changes…
-
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #37 · Wellbeing › Mental health · 18 Oct 2024 · 32 likes Expectations set by other people's reported trajectories are a documented source of distress, and the trajectories posted are not representative. It is one reading of…
-
Follow-up: Trifluoroacetate content and its consequences Replied, post #7 · Analytics › Impurities & related substances · 14 Oct 2024 · 11 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #127 · Access › Shortages · 13 Oct 2024 · 19 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #56 · Access › Shortages · 11 Oct 2024 · 23 likes Shortage status determines what compounding is permitted in some jurisdictions, which links two questions that otherwise seem unrelated.
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #29 · Compounds › Retatrutide · 10 Sep 2024 · 2 likes Narrowing post #26, because the general version has more than one answer. I think the hepatic effects of glucagon receptor question is answerable and has not been…
-
Orforglipron as a non-peptide: what changes when the molecule is small Replied, post #8 · Compounds › Oral incretins · 26 Aug 2024 · 0 likes Timing consistency matters more for oral dosing than for weekly injection, because absorption depends on the state of the stomach and the state of the stomach varies…
-
Circumference measurements as a poor man's composition estimate Replied, post #94 · Outcomes › Body composition · 24 Aug 2024 · 11 likes Post #92 is the version of this I will quote in future. One addition. Percentage body fat is a ratio, so it changes when either component changes. A rising percentage…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #50 · Practice › Dosing & titration · 23 Aug 2024 · 0 likes Having read the whole four-week escalation interval thread before replying: the question in the first post has not actually been answered yet, and three of us have…
-
Circumference measurements as a poor man's composition estimate Replied, post #77 · Outcomes › Body composition · 18 Aug 2024 · 10 likes Maintenance phase: tracking body composition during maintenance (weight stable) is different from tracking during active loss. Changes are smaller and precision becomes…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #54 · Compounds › Retatrutide · 19 Jul 2024 · 18 likes No disagreement from me. Posting only so the question does not look ignored.
-
Assessing a warm arrival: the decision process — one year on Replied, post #11 · Sourcing › Logistics · 28 May 2024 · 2 likes Practical experience of Assessing a warm arrival, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make…